Microarray expression profile analysis of long non-coding RNAs in human breast cancer: A study of Chinese women

Biomedicine and Pharmacotherapy

Volumn 69, Issue , 2015, Pages 221-227

  Xu, Nan ^a   Wang, Fengliang ^b   Lv, Mingming ^b   Cheng, Lu ^b  

^a NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b WOMEN S HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer; Immune system; LncRNA; Microarray; ZBTB46

Indexed keywords

COMPLEMENTARY DNA; LONG UNTRANSLATED RNA; MESSENGER RNA; WNT1 PROTEIN;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER GROWTH; CANCER IMMUNOLOGY; CHINESE; CLINICAL ARTICLE; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE MAPPING; GENE ONTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOREGULATION; MICROARRAY ANALYSIS; MOLECULAR LIBRARY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; RNA LIBRARY; UPREGULATION; ASIAN CONTINENTAL ANCESTRY GROUP; BREAST TUMOR; CHINA; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; REAL TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY;

ASIAN CONTINENTAL ANCESTRY GROUP; BREAST NEOPLASMS; CHINA; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE ONTOLOGY; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; RNA, LONG NONCODING;

EID: 84922218485     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2014.12.002     Document Type: Article

References (28)

1. De Santis C., Ma J., Bryan L., et al. Breast cancer statistics. CA Cancer J Clin 2014, 64(1):52-62.
2. Lee S., Stewart S., Nagtegaal I., et al. Differentially expressed genes regulating the progression of ductal carcinoma in situ to invasive breast cancer. Cancer Res 2012, 72(17):4574-4586.
3. Youlden D.R., Cramb S.M., Yip C.H., et al. Incidence and mortality of female breast cancer in the Asia-Pacific region. Cancer Biol Med 2014, 11(2):101.
4. Chen D.S., Mellman I. Oncology meets immunology: the cancer-immunity cycle. Immunity 2013, 39(1):1-10.
5. Bindea G., Mlecnik B., Angell H.K., et al. The immune landscape of human tumors: implications for cancer immunotherapy. Oncoimmunology 2014, 3(1):e27456.
6. Korkaya H., Liu S., Wicha M.S. Breast cancer stem cells, cytokine networks, and the tumor microenvironment. J Clin Invest 2011, 121(10):3804-3809.
7. Khodadadi A., Razmkhah M., Eskandari A.R., et al. IL-23/IL-27 ratio in peripheral blood of patients with breast cancer. Iran J Med Sci 2014, 39(4):350-356.
8. Du Z., Fei T., Verhaak R.G.W., et al. Integrative genomic analyses reveal clinically relevant long non-coding RNAs in human cancer. Nat Struct Mol Biol 2013, 20(7):908-913.
9. Ponting C.P., Oliver P.L., Reik W. Evolution and functions of long non-coding RNAs. Cell 2009, 136(4):629-641.
10. Cheetham S.W., Gruhl F., Mattick J.S., et al. Long non-coding RNAs and the genetics of cancer. Br J Cancer 2013, 108(12):2419-2425.
11. Zhang H., Chen Z., Wang X., et al. Long non-coding RNA: a new player in cancer. J Hematol Oncol 2013, 6(1):1-7.
12. Gupta R.A., Shah N., Wang K.C., et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 2010, 464(7291):1071-1076.
13. Huntley R.P., Harris M.A., Alam-Faruque Y., et al. A method for increasing expressivity of gene ontology annotations using a compositional approach. BMC Bioinformatics 2014, 15(1):155.
14. Khatri P., Sirota M., Butte A.J. Ten years of pathway analysis: current approaches and outstanding challenges. PLoS Comput Biol 2012, 8(2):e1002375.
15. Li J., Liu L., Li J., et al. Microarray expression profile of long non-coding RNAs in human osteosarcoma. Biochem Biophys Res Commun 2013, 433(2):200-206.
16. Prevarskaya N., Skryma R., Shuba Y. Calcium in tumour metastasis: new roles for known actors. Nat Rev Cancer 2011, 11(8):609-618.
17. Sallusto F. DCs: a dual bridge to protective immunity. Nat Immunol 2013, 14(9):890-891.
18. Song X., Zhou K., Zhao Y., et al. Fine mapping analysis of a region of 20q13.33 identified five independent susceptibility loci for glioma in a Chinese Han population. Carcinogenesis 2012, 33(5):1065-1071.
19. Akalay I., Tan T.Z., Kumar P., et al. Targeting WNT1-inducible signaling pathway protein 2 alters human breast cancer cell susceptibility to specific lysis through regulation of KLF-4 and miR-7 expression. Oncogene 2014, 10.1038/onc.2014.151.
20. Siegel R., Ma J., Zou Z., et al. Cancer statistics, 2014. CA Cancer J Clin 2014, 64(1):9-29.
21. Michailidou K., Hall P., Gonzalez-Neira A., et al. Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet 2013, 45(4):353-361.
22. Mercer T.R., Mattick J.S. Structure and function of long non-coding RNAs in epigenetic regulation. Nat Struct Mol Biol 2013, 20(3):300-307.
23. Qiu M.T., Hu J.W., Yin R., et al. Long non-coding RNA: an emerging paradigm of cancer research. Tumor Biol 2013, 34(2):613-620.
24. Rinn J.L., Kertesz M., Wang J.K., et al. Functional demarcation of active and silent chromatin domains in human HOX loci by non-coding RNAs. Cell 2007, 129(7):1311-1323.
25. Lu L., Zhu G., Zhang C., et al. Association of large non-coding RNA HOTAIR expression and its downstream intergenic CpG island methylation with survival in breast cancer. Breast Cancer Res Treat 2012, 136(3):875-883.
26. Butt A.Q., Mills K.H.G. Immunosuppressive networks and checkpoints controlling antitumor immunity and their blockade in the development of cancer immunotherapeutics and vaccines. Oncogene 2014, 33(38):4623-4631.
27. Grivennikov S.I., Greten F.R., Karin M. Immunity, inflammation, and cancer. Cell 2010, 140(6):883-899.
28. Shore A.N., Herschkowitz J.I., Rosen J.M. Non-coding RNAs involved in mammary gland development and tumorigenesis: there's a long way to go. J Mammary Gland Biol Neoplasia 2012, 17(1):43-58.